LR
Landry Robert E Chief Financial Officer
Other M
US US · SEC (Form 4)
Explore the complete record of transactions filed by Landry Robert E, Chief Financial Officer. Officer active across 1 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 15 reports have been recorded. Total volume traded: €373k. The latest transaction was filed on 7 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations 15 total
€551,771 1,500 shares @ €367.8471 0.0008% mcap 6.5% of flow
Common Stock
SEC:0001883850-22-000040:0 · 7 Apr 2022
€541,429 1,500 shares @ €360.9529 0.0007% mcap 6.4% of flow
Common Stock
SEC:0001883850-22-000028:0 · 31 Mar 2022
€631,797 1,250 shares @ €505.4374 0.0009% mcap 7.5% of flow
Common Stock
SEC:0001883850-22-000022:0 · 28 Mar 2022
€188,262 300 shares @ €627.5392 0.0003% mcap 2.2% of flow
Common Stock
SEC:0001708138-22-000028:0 · 21 Mar 2022
€185,152 300 shares @ €617.1735 0.0003% mcap 2.2% of flow
Common Stock
SEC:0001708138-22-000022:0 · 16 Mar 2022
€738,052 1,500 shares @ €492.0347 0.0010% mcap 23.3% of flow
Common Stock
SEC:0001883850-21-000028 · 10 Dec 2021
€738,052 1,500 shares @ €492.0347 0.0010% mcap 8.7% of flow
Common Stock
SEC:0001883850-21-000028:0 · 10 Dec 2021
03,971 shares 0
Common Stock
SEC:0001708138-21-000096 · 8 Dec 2021
03,971 shares 0
Common Stock
SEC:0001708138-21-000096:0 · 8 Dec 2021
€1m 3,750 shares @ €351.6129 0.0018% mcap 41.6% of flow
Common Stock
SEC:0001708138-21-000088 · 16 Nov 2021
€1m 3,750 shares @ €351.6129 0.0018% mcap 15.6% of flow
Common Stock
SEC:0001708138-21-000088:0 · 16 Nov 2021
€470,497 1,000 shares @ €470.4969 0.0006% mcap 14.8% of flow
Common Stock
SEC:0001708138-21-000070 · 31 Aug 2021
€470,497 1,000 shares @ €470.4969 0.0006% mcap 5.6% of flow
Common Stock
SEC:0001708138-21-000070:0 · 31 Aug 2021
€645,368 2,000 shares @ €322.6842 0.0009% mcap 20.3% of flow
Common Stock
SEC:0001708138-21-000050 · 6 Aug 2021
€645,368 2,000 shares @ €322.6842 0.0009% mcap 7.6% of flow
Common Stock
SEC:0001708138-21-000050:0 · 6 Aug 2021
About Landry Robert E Robert E Landry is an executive at REGENERON PHARMACEUTICALS, INC.